Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-21-003232
Date:2021-05-03
Issuer: BLUEBIRD BIO, INC. (BLUE)
Original Submission Date:

Reporting Person:

GREGORY PHILIP D
C/O BLUEBIRD BIO, INC.
60 BINNEY STREET CAMBRIDGE, MA 02142

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-05-03 S 39 d $30.15 46,829 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units.
f2 the range in prices for the transaction reported on this line was $29.85 to $30.42. the average weighted price was $30.1511. the reporting person will provide, upon request by the sec, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Elevate your investments